相关实验视频
Updated: May 3, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
严重的肺炎是由于同时感染了莱吉欧内拉肺炎和Acinetobacter baumannii:一个病例报告
Xiaoming Yang1, Zhongda Liu1, Xiaojing Liu1
1Department of Respiratory and Critical Care Medicine, Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang University of Traditional Chinese Medicine, No. 800 Zhongshan Road, Liandu District, Lishui, Zhejiang, 323000, China.
同时感染莱吉欧内拉肺炎和Acinetobacter baumannii可以导致严重的社区性肺炎. 早期检测和量身定制的抗生素治疗对于患者的康复至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 肺部病理学 肺部病理学
背景情况:
- 菌通常会导致社区获得的肺炎,而菌与医院获得的感染有关.
- 与两种病原体同时感染很少见,但可能导致严重的后果和高死亡率.
- 快速准确的诊断和治疗对于管理这些具有挑战性的感染至关重要.
研究的目的:
- 报告一种罕见的社区获得性肺炎病例,由同时感染莱吉欧内拉肺炎和Acinetobacter baumannii引起.
- 突出这种双重感染的诊断挑战和治疗策略.
主要方法:
- 一名患有严重社区性肺炎的患者被用经验性抗生素治疗.
- 支气管洗液的下一代元基因组测序 (mNGS) 确定了L. pneumophila和多药耐药的A. baumannii.
- 根据病原体识别和敏感性测试,调整了抗生素治疗方案.
主要成果:
- 患者的病情迅速恶化,尽管最初的经验治疗.
- mNGS成功地发现了同时发生的L. pneumophila和A. baumannii感染.
- 转换为奥马达环素和赛福拉/苏尔巴克坦导致肺炎的临床改善和解决.
结论:
- 在社区获得的肺炎可能是L. pneumophila和A. baumannii同时感染的结果.
- 密切监测,早期发现病原体和敏感性测试是必不可少的.
- 根据诊断结果量身定制抗生素治疗方案,在治疗失败的情况下改善了患者的治疗结果.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
相关概念视频
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Atypical Pneumonia
Pneumonia I: Introduction